A severe drought across vast area of Florida is wilting crops, sparking wildfires and sinking one of the country's largest lakes to historically low levels.
The majority of the state is experiencing the drought, prompted by La Nina conditions characterized by unusually cold ocean temperatures that are causing similar dry spells across the southern U.S., from New Mexico all the way to the Atlantic coast and north to Delaware.
"This one seems to be a different beast," said Brian Fuchs, a climatologist at the National Drought Mitigation Center at the University of Nebraska-Lincoln. "I think we're going to see things probably get worse before we see improvement."
Even as Florida starts its rainy season — which in its first week has been bone dry — showers can only do so much to reverse months of below-normal precipitation. A best-case scenario this summer might only lift the hardest-hit areas from the highest drought rating to one still rated severe.
The South Florida Water Management District, a 16-county area of central and South Florida with 7.7 million residents, recorded rainfall between Oct. 2 and Monday of just under 12.5 inches, nearly 11 inches below average. The period from October through February ranked as the driest such time frame in the district in 80 years.
That's drying out Lake Okeechobee, the backup reservoir for 5 million people, which stood at just 9.81 feet Wednesday, 3.32 feet below normal and approaching its all-time low of 8.82 feet set in July 2007. That drought ended in August 2008 when Tropical Storm Fay lingered over the state for almost a week, dropping 30 inches of rain in some spots.
Susan Sylvester, the water district's director of operations control, said the current problems are compounded by increased evaporation.
"Every root in every plant is trying to pull out some moisture," she said.
When the lake's levels are too low, it stops the natural gravity flow of its waters into canals that lead to water sources for millions of residents, in turn prompting irrigation restrictions. It also cuts flow to the ecologically fragile Everglades, causing navigation issues for boaters with ramps dried out and drying marsh areas on the lake's banks where wading birds forage for fish.
Rick Roth, a Belle Glade farmer, recently harvested radishes, green beans and lettuce. Radish yields were down about 5 percent, he said; green bean production was on par, but with the added expense of irrigation. And many heads of lettuce never reached full size.
A third-generation farmer who also grows sugarcane, corn and rice, Roth worries more about the crops going forward, particularly if the rainy season doesn't live up to its name.
"We're going to be in worse shape next year than we are this year," he said, "and this year we purely got by by the skin of our teeth."
Dale Erickson, whose farm near Pahokee grows mangoes, lychee and other crops, mustered a positive spin on lower yields. Even with his lychee production 40 percent below average, he had his best season in years, because he's been recovering from the loss of trees to an onslaught of hurricanes in 2004 and 2005. And compared with tornadoes, hurricanes and floods, Erickson says he'll take the drought.
"If we had any of the other ones, we'd be a lot worse," he said.
While many state residents are facing restrictions on watering their lawns, the extent of the drought hasn't hit home for most because in-home usage hasn't been affected. But one noticeable impact has been a string of wildfires blamed, in part, on the dry conditions.
Scott Petrich, wildfire mitigation specialist at the state's Division of Forestry, said 115 such fires have been recorded so far this year in its Everglades District, which includes Florida's four most southeasterly counties, mostly in unpopulated areas. That is nearly triple the normal level.
A motorist simply pulling a car into grass off the side of the road is enough to spark a fire in some areas, Petrich said. About a third of wildfires in the state are caused by lightning, which increases in the summer months.
"Until we get significant amounts of rainfall we're going to be faced with this situation," he said.
Smoke from one large fire west of Miami is closing some roads near the Miccosukee Indian Reservation, which has a large casino and resort. The fire, which began Sunday, has burned almost 30,000 acres but so far no homes are threatened. It is about 25 percent contained. The cause is unknown.
Fuchs said some relief is projected over the next two to three months but, particularly for farmers, the effects can be felt long after.
"The idea that the drought will go away rapidly — there's a chance of that — but right now it's not looking like it's going to," he said.
Copyright 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Citigroup’s revelation that hackers stole personal information from more than 200,000 credit card holders makes it one of the largest direct attacks on a major bank.
Even more striking is that similar data breaches have been occurring for years — and the financial industry has failed to prevent them.
Details remain scarce, but the disclosure of the Citigroup breach on Thursday quickly turned into a debate on whether the banks and major credit card companies had invested enough money to safeguard the personal information of their customers.
“They’re not at all on top of it,” said Avivah Litan, a financial security analyst at Gartner Inc. “It’s almost shocking.”
In Washington, the finger-pointing has already begun. Sheila C. Bair, the chairwoman of the Federal Deposit Insurance Corporation, said on Thursday that she planned to call on some banks to strengthen their authentication procedures when customers log onto online accounts. That’s on top of new data security rules that federal regulators are completing.
Lawmakers, meanwhile, said they were outraged that Citigroup waited since early May to notify its customers; some are preparing legislation.
Representative James R. Langevin, a Rhode Island Democrat, said he was “shocked and disappointed” to learn of Citi’s delayed disclosure. “They knew the customers’ data was potentially exposed in May and only now are they telling them about the threat,” he said. “Being more forthcoming is essential.”
Consumers, meanwhile, are feeling increasingly vulnerable amid recent reports of data breaches at big companies, like Lockheed Martin, Epsilon and Sony.
A. J. Angus, a 25-year-old Google employee, was put in double jeopardy. On Thursday, he learned that his Citi credit card data had been stolen. Only a few weeks earlier, he learned that personal data on his Sony PlayStation 3 was compromised.
“You have to be vigilant,” he said, adding that he periodically checks his credit report and looks over his transactions almost daily on a personal finance Web site.
On Thursday, Citigroup began notifying about half of the 200,000 affected customers that it planned to replace their credit cards after it discovered last month that hackers had gained access to its computer systems. The bank said that the thieves obtained customer names, card numbers, addresses, and e-mail details.
Social security numbers, expiration dates and the three-digit code found on the back of most credit cards were not compromised — a move that security experts say makes the exposed cardholders less likely to become fraud victims.
Neither Citigroup’s debit card business nor its online banking operations were breached.
“Citi has implemented enhanced procedures to prevent a recurrence of this type of event,” the company said in a statement.
The intrusion is not all that unique. Over the last six years, there have been 288 publicly disclosed breaches at financial services companies that exposed at least 83 million customer records, according to the Identity Theft Resource Center.
Credit card industry officials say security issues go to the heart of their brands and they are trying to keep up with ever-more sophisticated criminals.
“We’re not dealing with 14-year-old hacker kids,” said Steve Elefant, the chief information officer at Heartland Payment Systems, which overhauled its security measures after the systems it used to process credit and debit card transactions were hacked in 2008. “We’re talking about 21st-century bank robbers — sophisticated, organized criminal gangs, located mostly in Eastern Europe and the U.S.”
Making matters worse, nearly every step along the payment chain is outsourced from the time a card is swiped to the time a monthly statement arrives, leaving plenty of openings for enterprising thieves. Security is further hampered by a patchwork of data protection laws and regulatory agencies, each with limited mandates.
“We need a uniform national standard for data security and data breach notification,” said Representative Mary Bono Mack, a California Republican who is pushing for legislation on better consumer safeguards. “In the meantime, regulators need to do a better job of being a consumer watchdog.”
Big credit card lenders are loath to acknowledge another reason that the breaches keep happening: they are in the business of reducing the financial losses stemming from fraud, not preventing data theft in the first place. As a result, analysts say, they have devoted the bulk of their resources to trying to stop fraudulent transactions from occurring.
“Data breaches are one thing,” noted David Robertson, the publisher of The Nilson Report, a payments industry newsletter. “Acting on that information is another, and the systems in place to catch fraud when it is trying to be perpetrated are extremely good.”
Indeed, while the thieves have gotten more skilled, the amount of money the banks have lost to fraud has actually stayed the same over the last six years — and has sharply fallen since the early 1990s. Today, fraud costs the banks about 5 cents for every $100 that is charged, compared with 15 cents for every $100 in 1992, according to Nilson data.
Merchant advocates, meanwhile, say the banks have little incentive to reduce it more because, in some cases, it can be a source of income. Not only do they take in hefty charge-back fees from merchants — sometimes $25 or more for each fraudulent purchase — but in many cases retailers must swallow the cost of the item fraudulently purchased.
Preventing data theft from occurring seems to be a lower priority. After the huge credit card data breach of a payment processor in 2005, the major credit card companies banded together to form a set of security standards for the industry. But six years on, compliance with those rules has been mixed. Although virtually all of the 1,000 biggest merchants meet those requirements, far fewer than 60 percent of the millions of mom-and-pop retailers and online merchants do, according to Visa data.
Other proactive steps have also fallen by the wayside because of their cost. In Europe and Asia, most credit and debit card issuers have switched to cards that use small chips embedded inside the plastic that do a better job protecting transaction data. In the United States, the banks and card companies have not adopted the technology, reasoning that retailers are unwilling to spend heavily to upgrade their existing card readers.
Likewise, some security experts say encrypting data as it flows across the entire payment network would make data far less vulnerable to being extracted by thieves. However, only a tiny fraction of merchants and processors have upgraded their systems.
Mr. Elefant said the industry needed to adopt the encryptions technology more quickly. “Unfortunately, some companies look at breaches as the cost of doing business,” he said. “That’s not the right way to look at it. You need to be as secure as you possibly can be.”
Others suggest the banks need to do more to enlist their customers, like providing more regular fraud alerts and giving them more control to turn on and off their credit cards.
“What they don’t do enough of is engage the identity holder in the war against fraud,” said James Van Dyke of Javelin Strategy and Research, a payments consulting firm. “They greatly prefer to wage this battle solo.”
Tara Siegel Bernard, Riva Richmond and Nelson D. Schwartz contributed reporting.
This story originally appeared in The New York Times
Economic Headlines for June 10 2011 ( Friday ).
1) Import prices rose for an eight straight month in May despite a drop in fuel costs, with the year-on-year increase reaching its highest level in nearly three years, according to the Labor Department.
Import prices climbed 0.2 percent last month, confounding forecasts for a 0.7 percent decline and following April's revised 2.1 percent jump. In the year to May, import prices surged 12.5 percent, the largest gain since September 2008.
Exports prices rose 0.2 percent after a downwardly revised 0.9 percent gain. Analysts had been looking for a 0.3 percent gain.
Pharmaceutical Headlines for June 9, 2011 ( Thursday ).
• Halozyme Therapeutics, Inc. (HALO) and Intrexon Corporation Licensing Deal Valued at $63 Million More...
• Isconova Enters into Adjuvant License Agreement with Crucell N.V. (CRXL) More...
• Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of Second Antibody-Drug Conjugate (ADC) Under Existing Collaboration More...
• The Juvenile Diabetes Research Foundation and Selecta Biosciences, Inc. Enter Research Collaboration for Vaccines for Type 1 Diabetes More...
• Ambit Biosciences Withdraws IPO More...
• Access Scientific Completes $10 Million Financing Round More...
• Avantium Raises $43.9 Million to Advance YXY Technology More...
• Stratos Genomics Announces Financing for Validation of SBX(TM) Genome Sequencing Technology More...
• Northwest Biotherapeutics (NWBT) Announces Change and Expansion of Management Team: New CEO, COO, CSO and Senior VP More...
• NovaDel Pharma (NVD) Announces Changes in Management; CFO Resigns More...
• Gerry A. Higgins, Ph.D. Joins GenomeQuest, Inc. to Foster Development of Whole Genome Diagnostics More...
• PURE Bioscience (PURE) Names Craig Johnson as Chief Financial Officer More...
• Selecta Biosciences, Inc. Appoints Peter Keller as Vice President of Business Development and Alliance Management More...
• Enzo Biochem (ENZ) Schedules Teleconference to Discuss Fiscal Third Quarter Results on June 10, 2011 at 8:30 AM E.T. More...
• Pall Corporation (PLL) Reports Strong Third Quarter Results More...
• Repligen Corporation (RGEN) Reports Fourth Quarter and Fiscal Year 2011 Financial Results and Updates Expectations and Corporate Goals for Fiscal Year 2012 More...
• UCB SA Pleads Guilty to Illegal Off-Label Marketing of Epilepsy Drug Keppra; to Pay $34.4 Million More...
• Regenicin, Inc. (RGIN.OB) Announces Dismissal of Lawsuit More...
• U.S. District Court Rules in Favor of Eli Lilly and Company (LLY) in Amylin Pharmaceuticals, Inc. (AMLN) Litigation More...
• Regenicin, Inc. (RGIN.OB) Announces Advanced Discussions With Developers to Establish New Facilities in Florida More...
• France Suspends Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos and Competact Over Bladder Cancer Concerns More...
• FDA Announces New Limits On Merck & Co., Inc. (MRK)'s High-Dose Simvastatin (Zocor) More...
• Vertex Pharmaceuticals (MA) (VRTX) Slides as Cystic Fibrosis Drug Shows Promise but Also Raises Questions in Phase II Trial; Stock Falls 5.14 (9.67%) 12:56PM EDT More...
• Novartis AG Vaccine Shields Against Meningitis Cause More...
• XOMA (US) LLC (XOMA) Announces Phase 2a Six-Month Top Line Trial Results Support Safety and Biological Activity More...
• Abbott Laboratories (ABT) Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease More...
• Biomet Inc. (BMET) Announces Results of Phase I Clinical Trial for Critical Limb Ischemia Utilizing Autologous Concentrated Bone Marrow Aspirate More...
• Pill to Mend a Broken Heart 'Developed by Scientists' - University College London Study More...
• Concerns About High Folate Levels, National Institutes of Health (NIH) Study More...
• Immunomedics, Inc. (IMMU) Reports Advances With New Imaging Agent Developments for Positron Emission Tomography More...
• Respira Therapeutics Introduces Breakthrough Solutions For Respiratory Diseases More...
• Vitrolife: Clinical Study with Good Results Using STEEN Solution(TM) Published in Prestigious Scientific Journal More...
• Pfizer Inc. (PFE) Forms $100 Million Research Partnership with Boston-Area Schools and Hospitals More...
• Halozyme Therapeutics, Inc. (HALO) and Intrexon Corporation Licensing Deal Valued at $63 Million More...
• Isconova Enters into Adjuvant License Agreement with Crucell N.V. (CRXL) More...
• Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of Second Antibody-Drug Conjugate (ADC) Under Existing Collaboration More...
• The Juvenile Diabetes Research Foundation and Selecta Biosciences, Inc. Enter Research Collaboration for Vaccines for Type 1 Diabetes More...
• Ambit Biosciences Withdraws IPO More...
• Access Scientific Completes $10 Million Financing Round More...
• Avantium Raises $43.9 Million to Advance YXY Technology More...
• Stratos Genomics Announces Financing for Validation of SBX(TM) Genome Sequencing Technology More...
• Northwest Biotherapeutics (NWBT) Announces Change and Expansion of Management Team: New CEO, COO, CSO and Senior VP More...
• NovaDel Pharma (NVD) Announces Changes in Management; CFO Resigns More...
• Gerry A. Higgins, Ph.D. Joins GenomeQuest, Inc. to Foster Development of Whole Genome Diagnostics More...
• PURE Bioscience (PURE) Names Craig Johnson as Chief Financial Officer More...
• Selecta Biosciences, Inc. Appoints Peter Keller as Vice President of Business Development and Alliance Management More...
• Enzo Biochem (ENZ) Schedules Teleconference to Discuss Fiscal Third Quarter Results on June 10, 2011 at 8:30 AM E.T. More...
• Pall Corporation (PLL) Reports Strong Third Quarter Results More...
• Repligen Corporation (RGEN) Reports Fourth Quarter and Fiscal Year 2011 Financial Results and Updates Expectations and Corporate Goals for Fiscal Year 2012 More...
• UCB SA Pleads Guilty to Illegal Off-Label Marketing of Epilepsy Drug Keppra; to Pay $34.4 Million More...
• Regenicin, Inc. (RGIN.OB) Announces Dismissal of Lawsuit More...
• U.S. District Court Rules in Favor of Eli Lilly and Company (LLY) in Amylin Pharmaceuticals, Inc. (AMLN) Litigation More...
• Regenicin, Inc. (RGIN.OB) Announces Advanced Discussions With Developers to Establish New Facilities in Florida More...
• France Suspends Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos and Competact Over Bladder Cancer Concerns More...
• FDA Announces New Limits On Merck & Co., Inc. (MRK)'s High-Dose Simvastatin (Zocor) More...
• Vertex Pharmaceuticals (MA) (VRTX) Slides as Cystic Fibrosis Drug Shows Promise but Also Raises Questions in Phase II Trial; Stock Falls 5.14 (9.67%) 12:56PM EDT More...
• Novartis AG Vaccine Shields Against Meningitis Cause More...
• XOMA (US) LLC (XOMA) Announces Phase 2a Six-Month Top Line Trial Results Support Safety and Biological Activity More...
• Abbott Laboratories (ABT) Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease More...
• Biomet Inc. (BMET) Announces Results of Phase I Clinical Trial for Critical Limb Ischemia Utilizing Autologous Concentrated Bone Marrow Aspirate More...
• Pill to Mend a Broken Heart 'Developed by Scientists' - University College London Study More...
• Concerns About High Folate Levels, National Institutes of Health (NIH) Study More...
• Immunomedics, Inc. (IMMU) Reports Advances With New Imaging Agent Developments for Positron Emission Tomography More...
• Respira Therapeutics Introduces Breakthrough Solutions For Respiratory Diseases More...
• Vitrolife: Clinical Study with Good Results Using STEEN Solution(TM) Published in Prestigious Scientific Journal More...
Tech Five: Technology Headlines for June 9 2011 ( Thursday ) !!
1. Citigroup is the latest high-profile victim of a hack attack. The bank says that digital invaders breached its security and gained access to the credit card data for around 200,000 customers in North America. Names, contact numbers, and account details were accessed but more personal ID data, including the CVV codes of cards weren't compromised. Citi is contacting customers and won't say much more, but it's being argued it's an unforgivable breach.
2. The app patent suing round has taken an interesting turn, as ForSee Results has taken patent sue-rs Lodsys to court to invalidate its patent claims--in a Michigan court (far from patent-friendly Texas). Apple seems to be playing a careful legal role in the affair, and is seeking more data from affected developers. Meanwhile it's also bowed to pressure from U.S. politicians to bar DUI checkpoint apps from the App Store.
3. Coupons.com, the largest provider of digital coupons, just revealed it's raised around $200 million in investment cash based on a valuation figure of $1 billion. Institutional investors seem to be behind the money, implying they feel Coupons has a long term business strategy, and could pave the way for an IPO next year--yet more proof that the digital discount/coupon economy is flourishing like a weed on a sunny wet day.
4. Oracle has said it wouldn't support Intel Itanium processors, designed for servers, any longer in its software offerings. A simple enough decision you'd think, although we're not privy to the business plans. HP, on the other hand, is...via a pre-existing agreement. And now HP is demanding, on behalf of its enterprise customers, that Oracle reverse its decision--alleging it's a move to force Oracle customers onto Oracle hardware. Expect billion-dollar lawsuits if this goes wrong.
5. Salesforce.com, already a giant in cloud-based enterprise software, has no plans to sit contentedly still with its successful business, and has just bought the "data.com" domain name for "significantly" more than $1.5 million--placing it probably into the top 20 most expensive domains ever sold. We're not sure if it hints at a new service coming from Salesforce, or if it's a defensive purchase. But it's big money.
( Source: Fast Company )
1. Citigroup is the latest high-profile victim of a hack attack. The bank says that digital invaders breached its security and gained access to the credit card data for around 200,000 customers in North America. Names, contact numbers, and account details were accessed but more personal ID data, including the CVV codes of cards weren't compromised. Citi is contacting customers and won't say much more, but it's being argued it's an unforgivable breach.
2. The app patent suing round has taken an interesting turn, as ForSee Results has taken patent sue-rs Lodsys to court to invalidate its patent claims--in a Michigan court (far from patent-friendly Texas). Apple seems to be playing a careful legal role in the affair, and is seeking more data from affected developers. Meanwhile it's also bowed to pressure from U.S. politicians to bar DUI checkpoint apps from the App Store.
3. Coupons.com, the largest provider of digital coupons, just revealed it's raised around $200 million in investment cash based on a valuation figure of $1 billion. Institutional investors seem to be behind the money, implying they feel Coupons has a long term business strategy, and could pave the way for an IPO next year--yet more proof that the digital discount/coupon economy is flourishing like a weed on a sunny wet day.
4. Oracle has said it wouldn't support Intel Itanium processors, designed for servers, any longer in its software offerings. A simple enough decision you'd think, although we're not privy to the business plans. HP, on the other hand, is...via a pre-existing agreement. And now HP is demanding, on behalf of its enterprise customers, that Oracle reverse its decision--alleging it's a move to force Oracle customers onto Oracle hardware. Expect billion-dollar lawsuits if this goes wrong.
5. Salesforce.com, already a giant in cloud-based enterprise software, has no plans to sit contentedly still with its successful business, and has just bought the "data.com" domain name for "significantly" more than $1.5 million--placing it probably into the top 20 most expensive domains ever sold. We're not sure if it hints at a new service coming from Salesforce, or if it's a defensive purchase. But it's big money.
( Source: Fast Company )
Immucell Corp ( NASDAQ: ICCC ), stock jumped after company has announced that Center for Veterinary Medicine, USFDA has accepted the data of Nisin Residue in milk. Stock jumped more than 20%. Liquidity in the stock is low and there might be a hight risk game to trade the stock.
Our Call: We think the news might not significant enough to trigger a huge upside in the stock and Traders might stay away to play the stock based on news.
Below is the news from Reuters:
ImmuCell Corporation announced that the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA) has accepted the pivotal Nisin residue data in milk and has assigned a zero milk discard time and zero meat withdrawal period. These claims are subject to obtaining the Human Food Safety (HFS) Technical Section Complete Letter and ultimately approval of the New Animal Drug Application (NADA). Zero Discard means that there would be no requirement to discard milk during treatment or for a period of time thereafter.
Economic Headlines for June 9 2011 ( Thursday ).
1) Jobless claims edge higher as per the report from labor department The number of Americans filing new claims for unemployment aid unexpectedly edged higher last week, stoking fears of a stalled economic recovery even as a separate report showed record U.S. exports in April.
Initial claims for state jobless benefits increased 1,000 to 427,000, the Labor Department said. However, economists polled by Reuters had forecast claims dropping to 415,000 from a previously reported count of 422,000.
2) Trade deficit narrowed in April according to the Commerce Department, as U.S. exports rose to a new record and imports from Japan tumbled more than 25 percent after its earthquake, tsunami and nuclear disaster.
The monthly trade gap totaled $43.7 billion, down 6.7 percent from a revised estimate of $46.8 billion in March which was originally reported as $48.2 billion.
The $3 billion drop in imports from Japan from March to April was the largest on record. U.S. auto and auto parts imports from Japan and other suppliers fell $2.8 billion, partly reflecting supply chain disruptions in the aftermath of the triple disaster.
3) Wholesale inventories rose less than forecast in April, but seemed enough to boost investor confidence and stocks.
Inventories rose 0.8 percent to $447.2 billion in the first month of the second quarter, below economists forecasts of 1.0 percent, according to the Commerce Department. Automotive inventories, one of the biggest categories, fell 1.3 percent. Wholesale inventories have increased 16.6 percent since hitting a low in September 2009.
Coffee Holdings Co Inc ( NASDAQ: JVA ), company has announced quarterly dividend of $0.03 per share payable to common stockholders as of the close of business on July 18, 2011. The dividend will be paid on August 1, 2011.
Stock jumped more than 40 % to $11.90. Volumes are abnormally high and an up move might be considered a breakout. stock might be considered for trade or investment purpose.
Daily Digest Stockinvestips |
Upgrades for June 8, 2011 Wednesday:
1) Bob Evans ( NASDAQ: BOBE) upgraded from hold to buy by Miller Tabak.
2) Cabot Oil & Gas ( NYSE : COG) upgraded from hold to buy by Canaccord Genuity.
3) Carrizo Oil & Gas ( NASDAQ: CRZO) upgraded from Mkt Perform to Mkt Outperform by Howard Weil.
4) Clearwire ( NASDAQ: CLWR ) upgraded from hold to buy by Kaufman Bros.
8) Franklin Resources ( NYSE: BEN) upgraded from neutral to buy by Ticonderoga.
5) Dolby Labs ( NYSE: DLB) upgraded from hold to buy by Brigantine.
6) Ensco( NYSE: ESV) upgraded from hold to buy by Dahlman Rose .
7) Foster Wheeler ( NASDAQ: FWLT) upgraded from hold to buy by BB&T Capital Mkts.
8) Franklin Resources ( NYSE: BEN) upgraded from neutral to buy by Ticonderoga.
9) G-III Apparel ( NASDAQ: GIII) upgraded from hold to buy by KeyBanc Capital Mkts.
10) Noble Corp ( NYSE : NE ) upgraded from hold to buy by Dahlman Rose.
11) Northern Oil & Gas ( AMEX : NOG ) upgraded from add to strong buy by CapitalOne southcoast.
11) Northern Oil & Gas ( AMEX : NOG ) upgraded from add to strong buy by CapitalOne southcoast.
12) Verizon ( NYSE : VZ) upgraded from perform to outperform by Oppenheimer.
See More
Downgrades for June 8, 2011 Wednesday:
1) Cogo Group ( NASDAQ : COGO) downgraded from buy to neutral by Ticonderoga .
2) Gap ( NYSE : GPS) downgraded from overweight to equal weight by Barclays Capital.
3) Sunpower ( NASDAQ : SPWRA ) downgraded from hold to under perform by Needham .
4) Varian Semi ( NASDAQ : VSEA) downgraded from overweight to equal weight by Barclays Capital.
See More
Coverage Initiated for June 8, 2011 Wednesday:
1) Kinder Morgan ( NYSE : KMI ) coverage initiated with hold by Deutsche Bank.
2) Rentrak ( NASDAQ : RENT ) coverage initiated with buy by Collins Stewart.
3) Tesoro Logistics LP ( NYSE : TLLP ) coverage initiated with over weight by Barclays Capital.
4) ViaSat ( NASDAQ: VSAT ) coverage initiated with Mkt Perform by Morgan Keegan.
2) Rentrak ( NASDAQ : RENT ) coverage initiated with buy by Collins Stewart.
3) Tesoro Logistics LP ( NYSE : TLLP ) coverage initiated with over weight by Barclays Capital.
4) ViaSat ( NASDAQ: VSAT ) coverage initiated with Mkt Perform by Morgan Keegan.
See More here at stockinvestips
Pharmaceutical Headlines for June 8, 2011 ( Wednesday ).
• Pfizer Inc. (PFE) Seeks to Cut $1 Billion in Costs; Cuts are in Addition to Those Previously Announced in the Company's R&D Ops More...
• Grifols' CEO Sees Few Cuts at Talecris Biotherapeutics (TLCR); Expects Layoffs to be Less Than 5% More...
• PAREXEL International (PRXL) to Close Four Sites in Early Stage Cuts; Will Cut Bed Count By 28 Per Cent And Cause Around 300 Layoffs More...
• Northeast Pharma Announces $370 Million Private Placement More...
• Covidien (COV) Seeks Buyer for its Pharma Unit; Looking to Seek as Much as $4 Billion More...
• Paladin Labs Inc. (CC:PLB) Seals $5.5M Cash and Equity Agreement for Somaxon Pharmaceuticals, Inc. (SOMX)'s Insomnia Drug More...
• Biogen Idec, Inc. (Massachusetts) (BIIB) Seeking Deals to Expand Pipeline of MS Treatments More...
• Affectis Pharmaceuticals AG and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases More...
• Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products More...
• Actelion Ltd. (ALIOF.PK) Appoints COO in Management Shake-up, Creates Biotech Startup More...
• TetraLogic Pharmaceuticals Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development More...
• China Pharmaceuticals (CFMID.OB) Announces Results for First Quarter 2011 More...
• Eli Lilly and Company (LLY) to Settle Dispute Over Drug Copies More...
• Abattis Clarifies Position on IP Acquisition from Former Zicam® DeveloperMore...
• Merck & Co., Inc. (MRK) and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 More...
• RXi Pharmaceuticals (RXII) Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at American Society of Clinical Oncology More...
• Medicago, Inc. Reports Positive U.S. Clinical Trial Results for Its H1N1 / Seasonal Influenza Vaccine More...
• Chroma Therapeutics and Cell Therapeutics, Inc. (CTIC) Announce New Positive Interim Phase II Data for Tosedostat in AML OPAL Study, Revealed at American Society of Clinical Oncology More...
• Genta Incorporated (GETA.OB) Release: Tesetaxel Results From Multiple Dose-Ranging Clinical Trials Updated at American Society of Clinical Oncology More...
• Almirall and GW Pharmaceuticals Release: Sativex(R) Approved in Denmark for the Treatment of Spasticity Due to Multiple Sclerosis (MS) More...
• Incyte Corporation (INCY) Seeks Accelerated FDA Approval More...
• FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer More...
• Coffee Drinking Improves Hepatitis C Treatment Response, Study Published in Gastroenterology More...
• Researchers Discover Biochemical Weakness of Malaria Parasite - Vaccine to be Developed, University of Copenhagen Study More...
• Older Age Does Not Cause Testosterone Levels to Decline in Healthy Men,University of Sydney Study More...
• Scots Patients Help to Pioneer New Treatment to 'Melt Away' Asthma,University Hospital of South Manchester Study More...
• Sex Supplement Improves Life of Cancer Survivors, Wake Forest University Baptist Medical Center Study More...
• Pfizer Inc. (PFE) Seeks to Cut $1 Billion in Costs; Cuts are in Addition to Those Previously Announced in the Company's R&D Ops More...
• Grifols' CEO Sees Few Cuts at Talecris Biotherapeutics (TLCR); Expects Layoffs to be Less Than 5% More...
• PAREXEL International (PRXL) to Close Four Sites in Early Stage Cuts; Will Cut Bed Count By 28 Per Cent And Cause Around 300 Layoffs More...
• Northeast Pharma Announces $370 Million Private Placement More...
• Covidien (COV) Seeks Buyer for its Pharma Unit; Looking to Seek as Much as $4 Billion More...
• Paladin Labs Inc. (CC:PLB) Seals $5.5M Cash and Equity Agreement for Somaxon Pharmaceuticals, Inc. (SOMX)'s Insomnia Drug More...
• Biogen Idec, Inc. (Massachusetts) (BIIB) Seeking Deals to Expand Pipeline of MS Treatments More...
• Affectis Pharmaceuticals AG and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases More...
• Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products More...
• Actelion Ltd. (ALIOF.PK) Appoints COO in Management Shake-up, Creates Biotech Startup More...
• TetraLogic Pharmaceuticals Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development More...
• China Pharmaceuticals (CFMID.OB) Announces Results for First Quarter 2011 More...
• Eli Lilly and Company (LLY) to Settle Dispute Over Drug Copies More...
• Abattis Clarifies Position on IP Acquisition from Former Zicam® DeveloperMore...
• Merck & Co., Inc. (MRK) and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 More...
• RXi Pharmaceuticals (RXII) Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at American Society of Clinical Oncology More...
• Medicago, Inc. Reports Positive U.S. Clinical Trial Results for Its H1N1 / Seasonal Influenza Vaccine More...
• Chroma Therapeutics and Cell Therapeutics, Inc. (CTIC) Announce New Positive Interim Phase II Data for Tosedostat in AML OPAL Study, Revealed at American Society of Clinical Oncology More...
• Genta Incorporated (GETA.OB) Release: Tesetaxel Results From Multiple Dose-Ranging Clinical Trials Updated at American Society of Clinical Oncology More...
• Almirall and GW Pharmaceuticals Release: Sativex(R) Approved in Denmark for the Treatment of Spasticity Due to Multiple Sclerosis (MS) More...
• Incyte Corporation (INCY) Seeks Accelerated FDA Approval More...
• FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer More...
• Coffee Drinking Improves Hepatitis C Treatment Response, Study Published in Gastroenterology More...
• Researchers Discover Biochemical Weakness of Malaria Parasite - Vaccine to be Developed, University of Copenhagen Study More...
• Older Age Does Not Cause Testosterone Levels to Decline in Healthy Men,University of Sydney Study More...
• Scots Patients Help to Pioneer New Treatment to 'Melt Away' Asthma,University Hospital of South Manchester Study More...
• Sex Supplement Improves Life of Cancer Survivors, Wake Forest University Baptist Medical Center Study More...
( Source: Biospace )